US Patent Issued to SHENZHEN JIKANG PHARMACEUTICAL TECHNOLOGY on Sept. 1 for "Triazole derivative, method for preparing same, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,037, issued on Sept. 1, was assigned to SHENZHEN JIKANG PHARMACEUTICAL TECHNOLOGY Co. LTD. (Shenzhen, China).

"Triazole derivative, method for preparing same, and use thereof" was invented by Yongqiang Zhu (Shenzhen, China), Meng Lei (Shenzhen, China), Hang Miao (Shenzhen, China) and Xueyuan Wang (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The technical field of pharmaceuticals. Disclosed are a triazole derivative, a method for preparing same, and use thereof. The triazole derivative has a structure as shown in formula I, and the triazole derivative of the present invention can be used as a CRM1 inhibitor for preparing a medicame...